Nature Clinical Practice Oncology
Therapy Insight: Anthracyclines and Trastuzumab - The Optimal Management of Cardiotoxic Side Effects CME

Disclosures

Release Date: March 25, 2008; Valid for credit through March 25, 2009
Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

Contents of This CME Activity
    To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.
    Therapy Insight: Anthracyclines and Trastuzumab - The Optimal Management of Cardiotoxic Side Effects
    Sanjay Popat, BSc, MB, MRCP, PhD
    Ian E. Smith, MD, FRCP

Go to Test Questions

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2008 Medscape.

 
Medscape
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Identify the interaction of anthracycline and trastuzumab in the promotion of cardiotoxicity
  2. Describe clinical practices to reduce the risk for trastuzumab-associated cardiotoxicity
  3. Specify the interaction between radiation therapy and trastuzumab in promoting cardiotoxicity
Authors and Disclosures

Sanjay Popat, BSc, MB, MRCP, PhD
Disclosure: Sanjay Popat, BSc, MB, MRCP, PhD, has disclosed no relevant financial relationships.


Ian E. Smith, MD, FRCP
Disclosure: Ian E. Smith, MD, FRCP, has declared that he serves on the speakers' bureau for Roche.


Charles P. Vega, MD
Disclosure: Charles P. Vega, MD, has disclosed that he has served as an advisor or consultant to Novartis, Inc.


Lisa Hutchinson
Disclosure: Lisa Hutchinson has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.